NANOG and breast cancer: In this study, we have shown that Δ40p53 co-localises with stem cell markers in breast cancer cells (Fig. 2) and its overexpression led to an increase in pluripotency markers (SOX2, OCT4, NANOG, and ZEB1) and a stemness phenotype (Fig. 3).